tradingkey.logo
tradingkey.logo
Search

Kashiv Biosciences Announces Positive Topline Results From Confirmatory Efficacy Study Of ADL-018

ReutersJun 25, 2025 12:19 PM
facebooktwitterlinkedin

-

  • KASHIV BIOSCIENCES ANNOUNCES POSITIVE TOPLINE RESULTS FROM CONFIRMATORY EFFICACY STUDY OF ADL-018, BIOSIMILAR CANDIDATE TO XOLAIR® (OMALIZUMAB)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI